CHRISTY BEASLEY: Open Payments
NPI 1194763607 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 25 payments from 14 companies in 2025. Trend: 2023 $462 · 2024 $655 · 2025 $535
Food & beverage: $431Education: $103
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Genentech USA, Inc. | 1 | $53 |
| SOBI, INC | 1 | $50 |
| PFIZER INC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Aveo Pharmaceuticals, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Genmab U.S., Inc. | 1 | $21 |
| JAZZ PHARMACEUTICALS INC. | 1 | $21 |
Products named: VENCLEXTA, KISQALI, EPKINLY, FOTIVDA, Nubeqa, XTANDI, ZEPZELCA, MONJUVI.
Industry payments across OK — which companies pay providers there.
